Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Median“
Suchtreffer
Begriffe & Kennungen
Casgevy · 4.8 · In study 111, the median (min, max) time to platelet engraftment in patients with TDT was 44 (20, 200) days (n
Eintrag öffnenCasgevy · 4.8 · In study 121, the median (min, max) time to neutrophil engraftment in patients with SCD was 27 (15, 40) days (
Eintrag öffnenCasgevy · 4.8 · In study 121, the median (min, max) time to platelet engraftment for patients with SCD was 35 (23, 126) days (
Eintrag öffnenCasgevy · 4.8 · The median (min, max) duration of follow-up after being administered Casgevy was 22.8 (2.1, 51.1) months for p
Eintrag öffnenColumvi · 4.8 · Grade 2 CRS occurred in 10.5% of patients following the first Columvi dose (2.5 mg) with median time to onse
Eintrag öffnenColumvi · 4.8 · Grade 2 CRS occurred in 12.4% of patients following the first Columvi dose (2.5 mg) with median time to onse
Eintrag öffnenColumvi · 4.8 · The observed time to onset of the majority of ICANS was 1-7 days with median of 2 days after the most recent d
Eintrag öffnenDapagliflozin Viatris · 4.8 · Diabetic ketoacidosis in type 2 diabetes mellitus In the DECLARE study, with a median exposure time of 48 mont
Eintrag öffnenDapagliflozin Viatris · 4.8 · In the DECLARE study with 17 160 type 2 diabetes mellitus patients and a median exposure time of 48 months, a
Eintrag öffnenDarzalex · 4.8 · The median time to onset of a reaction was 1.5 hours (range: 0 to 72.8 hours). The incidence of infusion modif
Eintrag öffnenDarzalex · 4.8 · With a median follow-up of 11.4 months, overall deaths (D-VCd 14% vs. VCd 15%) in study AMY3001 were primarily
Eintrag öffnenDegevma · 4.8 · 8 The trials in patients with breast or prostate cancer included a denosumab extension treatment phase (median
Eintrag öffnenDescovy · 4.8 · 14 changes from baseline). There was little change from baseline in median fasting values for HDL cholesterol
Eintrag öffnenDescovy · 4.8 · 40 changes from baseline). There was little change from baseline in median fasting values for HDL cholesterol
Eintrag öffnenDocetaxel Accord · 4.8 · General disorders and administration site conditions The median cumulative dose to treatment discontinuation w
Eintrag öffnenDocetaxel Kabi · 4.8 · 24 due to AML during the follow-up period (median follow-up time of 8 years). Myelodysplastic syndrome was rep
Eintrag öffnenDocetaxel Kabi · 4.8 · 70 due to AML during the follow-up period (median follow-up time of 8 years). Myelodysplastic syndrome was rep
Eintrag öffnenDocetaxel Kabi · 4.8 · General disorders and administration site conditions The median cumulative dose to treatment discontinuation w
Eintrag öffnenDocetaxel Kabi · 4.8 · General disorders and administration site conditions The median cumulative dose to treatment discontinuation w
Eintrag öffnenDocetaxel Kabi · 4.8 · General disorders and administration site conditions The median cumulative dose to treatment discontinuation w
Eintrag öffnen